CNCR vs. XPH ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to SPDR S&P Pharmaceuticals ETF (XPH)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$14.74

Average Daily Volume

3,771

Number of Holdings *

67

* may have additional holdings in another (foreign) market
XPH

SPDR S&P Pharmaceuticals ETF

XPH Description The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Grade (RS Rating)

Last Trade

$46.16

Average Daily Volume

40,383

Number of Holdings *

44

* may have additional holdings in another (foreign) market
Performance
Period CNCR XPH
30 Days 0.07% 4.18%
60 Days -2.25% 3.86%
90 Days 3.58% 9.06%
12 Months 45.65% 28.77%
5 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in XPH Overlap
ARVN C 1.42% 2.76% 1.42%
BMY A 1.43% 3.75% 1.43%
ELVN B 1.75% 0.75% 0.75%
MRK F 1.22% 3.18% 1.22%
NUVB F 1.02% 0.49% 0.49%
CNCR Overweight 62 Positions Relative to XPH
Symbol Grade Weight
BMEA D 1.91%
TYRA F 1.89%
HCM C 1.74%
ACLX B 1.55%
REPL B 1.55%
MGNX C 1.55%
YMAB A 1.54%
AURA B 1.54%
AUTL D 1.51%
KPTI C 1.5%
RVMD A 1.47%
DAWN A 1.42%
TSVT D 1.42%
MRUS C 1.41%
MRSN D 1.41%
JANX A 1.4%
EXEL A 1.39%
RPTX C 1.39%
RCUS F 1.38%
IGMS B 1.37%
BCYC D 1.37%
SNDX F 1.37%
KYMR C 1.36%
XNCR A 1.35%
IOVA B 1.35%
ALLO D 1.35%
GNLX C 1.32%
BPMC C 1.32%
ACRV B 1.32%
IMCR F 1.31%
NRIX B 1.31%
ACET F 1.3%
CRBU D 1.28%
STRO D 1.28%
RXRX F 1.28%
PGEN F 1.27%
GERN C 1.26%
LYEL F 1.25%
CGEM F 1.24%
SDGR F 1.23%
RAPT D 1.23%
ERAS C 1.23%
ZNTL D 1.22%
BNTX B 1.21%
IPHA D 1.18%
GLUE A 1.17%
LEGN F 1.16%
GMAB F 1.15%
NUVL D 1.13%
FHTX C 1.11%
REGN F 1.1%
KURA F 1.1%
SWTX D 1.09%
IDYA F 1.08%
RLAY F 1.05%
FATE F 1.03%
IMRX D 1.02%
ITOS F 0.99%
IMTX F 0.99%
VOR D 0.94%
SMMT C 0.92%
PRLD F 0.85%
CNCR Underweight 39 Positions Relative to XPH
Symbol Grade Weight
CORT B -4.32%
LBPH A -4.15%
EWTX B -3.64%
ITCI A -3.49%
CTLT D -3.47%
JAZZ D -3.46%
JNJ D -3.44%
RPRX D -3.43%
VTRS B -3.43%
PFE D -3.41%
LLY F -3.36%
ZTS D -3.31%
AXSM C -3.3%
PRGO D -3.15%
ELAN D -2.98%
OGN D -2.93%
SAVA D -2.7%
TARS A -2.36%
AMPH A -2.25%
PBH A -2.22%
SUPN B -2.03%
PCRX C -2.01%
LGND A -1.72%
COLL F -1.69%
OCUL B -1.59%
ANIP F -1.57%
HROW C -1.46%
HRMY D -1.27%
AMRX B -1.24%
WVE B -1.16%
INVA C -1.02%
LQDA C -0.99%
PLRX A -0.93%
MNMD C -0.9%
EYPT C -0.87%
PHAT B -0.87%
FULC F -0.83%
EOLS A -0.7%
XERS A -0.49%
Compare ETFs